Inflammation

Anti-Inflammatory Diets May Help Reduce Risk of Alzheimer Disease–Related Death

June 6th 2025

Anti-inflammatory diet | Image Credit: monticellllo - stock.adobe.com

New Evidence Links Arthritis to Increased Prostate Cancer Risk

May 15th 2025

Prostate cancer awareness | Image Credit: ActionGP - stock.adobe.com

Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

May 9th 2025

Woman measuring man's waist with tape measure | Image Credit: fotoduets - stock.adobe.com

April 23rd 2025

Continuing Medical Education

View All

1.5 Credits / Dermatology, Immunology

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

1.5 Credits / Allergy, Immunology

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Immunology, Allergy

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Pulmonology

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

1.5 Credits / Immunology

1.5 Credits / Gastroenterology, Immunology

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.0 Credit / Immunology, Nephrology

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

More News

November 23rd 2022

Exploring Current Eosinophilic Gastrointestinal Disease Nomenclature and Management

Rose McNulty

An article published in the journal Gastroenterology & Hepatology highlights recent updates to eosinophilic gastrointestinal disease nomenclature, as well as updates related to diagnosis, pathogenesis, and treatment standards.

November 21st 2022

Previous Infections May Increase Risk of EoE, Study Finds

Jared Kaltwasser

The study findings suggest that eosinophilic esophagitis (EoE), like other atopic diseases, may be associated with infections.

November 19th 2022

Disease Characteristics Vary Widely Among Patients With CRSwNP or CRSsNP

The investigators of this new study wanted to more clearly define the patient characteristics of the 2 main types of chronic rhinosinusitis: with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP).

November 9th 2022

Nasal Cytology Produces Comparable Results to Surgery in CRSwNP

The investigators of a new study evaluated if nasal cytology was a reliable method to identify type 2 inflammation in patients who have chronic rhinosinusitis with nasal polyps (CRSwNP), which could then facilitate patient selection for biological drug utilization via endotypization.

October 31st 2022

Urgent Need for CRSwNP Treatment Optimization in Finland

A significant uptick in chronic rhinosinusitis with nasal polyps (CRSwNP) among patients with comorbid asthma has been seen in the country over the past decade.

October 27th 2022

Minor Motility Disorders Common in EoE, Says Meta-Analysis

The findings follow recent data suggesting that esophageal dysmotility may be associated with eosinophilic esophagitis (EoE), which often presents with dysphagia.

Image of foods that can trigger a reaction

October 26th 2022

Fixed Structural Disease May Predict EoE Response to Elimination Diet

The study, say researchers, adds insight into risk factors predictive of response to dietary intervention for eosinophilic esophagitis (EoE), as dietary failure occurs in up to 30% of patients.

October 22nd 2022

New Index Aims to Help Clinicians Gauge Severity of EoE Cases

Jared Kaltwasser

The index for eosinophilic esophagitis (EoE) was crafted based on a literature review by a multidisciplinary team of experts.

October 20th 2022

CRSwNP Likely Leads to Greater Overall Disease Burden Following Surgery

The goal of this new study was to gain more information on the disease burden, including costs, of patients living with chronic rhinosinusitis with nasal polyps (CRSwNP).

October 18th 2022

Patients With Asthma, Other Allergic Diseases May Have Higher Prevalence of EoE

While the prevalence of eosinophilic esophagitis (EoE) is estimated to be 0.5% in the general population, a recent study found that the prevalence was as high as 16.5% in patients with allergic disease.

October 12th 2022

Review Finds Insufficient Evidence Supporting Corticosteroid Irrigation for CRS With Nasal Polyps

Christina Mattina

A search of the peer-reviewed literature turned up inconsistent findings on the effectiveness of corticosteroid irrigation for the treatment of chronic rhinosinusitis (CRS) with nasal polyps.

October 8th 2022

Dupilumab Outcomes Similar in CRSwNP Among Treatment-Naïve, Postsurgical Patients

The effect of dupilumab was investigated among patients with severe and uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP).

Image of a person with an irritated nose

October 4th 2022

Periostin as Biomarker May Be More Useful Than Eosinophils in ECRS

Despite extensive study, eosinophilic chronic rhinosinusitis (ECRS) remains a significant health problem with few effective treatments, so this study compared periostin levels among those who did and did not have ECRS to assess its potential as a disease biomarker.

September 30th 2022

Four Factors Identified as Potential Risks for Comorbid CRSwNP, Asthma

Researchers investigated potential risk factors for the higher occurrence of asthma among individuals who have chronic rhinosinusitis with nasal polyps (CRSwNP).

September 28th 2022

Real-world EoE Data Show More, Quicker Responses Among Concurrent Eczema, PFS

Overall, 65% of patients went into remission throughout the observation period, with those with concurrent eczema and pollen food syndrome (PFS) having favorable responses.

September 28th 2022

Pediatric ESS Effective, Safe to Treat Chronic Sinusitis With Nasal Polyps

With a high recurrence rate following surgery to treat chronic sinusitis with nasal polyps, authors set out to investigate the effectiveness and safety of endoscopic sinus surgery (ESS) in a pediatric patient population.

September 23rd 2022

Examining Biologic-Related Adverse Events in CRS With Nasal Polyps

Matthew Gavidia

Headaches, injection site reactions, and pharyngitis were the most common adverse events associated with the biologic therapies dupilumab, omalizumab, mepolizumab, and reslizumab in the treatment of chronic rhinosinusitis (CRS) with nasal polyps.

September 17th 2022

Antibody Level Linked to Milk Proteins, Consumption in Eosinophilic Esophagitis

It is already known that patients with eosinophilic esophagitis have higher levels of immunoglobulin G4, and this study examined the relationship to specific foods and aeroallergens.

Graphic showing figure on the outside of a group

September 15th 2022

Researchers Evaluate Racism as a Factor in Underestimation of Atopic Disease

Although allergic and atopic disease is well studied and researched overall, the researchers said there is a critical lack of knowledge about these conditions, including eosinophilic esophagitis, asthma, and atopic dermatitis, in diverse racial and ethnic groups.

September 14th 2022

Risk Factors for CRS Plus Asthma Differ Among Younger vs Older Patients

Risk factors as predictors of asthma prevalence among a cohort of patients living with chronic rhinosinusitis (CRS), as they related to age, were evaluated by clinical investigators from the College of Medicine at Korea University.

September 9th 2022

SCS Use May Predispose Patients Who Have CRSwNP to Worse Health Outcomes

Using systemic corticosteroids (SCS) to treat chronic rhinosinusitis with nasal polyps (CRSwNP) has been linked to adverse outcomes among patients, prompting these study investigators to compare their health care resource utilization with that of patients who have CRSwNP but don’t use SCS.

September 8th 2022

OIT Can Continue Even if EoE Develops, Researchers Say

A recent study attempted to determine the prevalence of eosinophilic esophagitis (EoE) in a group of patients allergic to milk or egg and undergoing oral immunotherapy (OIT) to those foods, as well as describe its management and treatment pathway.

September 2nd 2022

Success in Eosinophil-Targeted Treatments for EoE Remains Limited

The researchers compiled data from studies of lirentelimab, mepolizumab, reslizumab, and benralizumab, highlighting the difficulties in finding an effective approach with eosinophil-targeted treatments for eosinophilic esophagitis (EoE).

August 30th 2022

Bradykinin Level Displays Biomarker Benefit in Nasal Polyposis

With evidence lacking on the role of inflammation in nasal polyposis (NP), this study investigated the role of 2 potential biomarkers in the nasal secretions of patients who have NP concomitant with aspirin-exacerbated respiratory disease.

August 27th 2022

Researchers Reexamine Budesonide for EoE in Meta-Analysis

AJMC Staff

In this study, researchers reaffirmed the safety and efficacy of using budesonide to treat eosinophilic esophagitis (EoE).

August 25th 2022

Combination Treatment Provides Short-term Endoscopic Relief in CRSwNP Subtype

This study investigated combination treatment of antibiotics plus corticosteroids among persons with aspirin-exacerbated respiratory disease, a subtype of chronic rhinosinusitis with nasal polyposis (CRSwNP).

August 18th 2022

Adherence to INC Treatment for Nasal Polyposis Remains Low

Despite intranasal corticosteroid (INCs) being a treatment mainstay for chronic rhinosinusitis with nasal polyps, there are ongoing high rates of nonadherence, which can affect treatment efficacy, according to this study’s authors.

August 12th 2022

Researchers Advocate for Closer Monitoring of Patients With EoE

A study of adult patients with eosinophilic esophagitis in remission showed that those who were followed more closely in the maintenance phase of treatment had fewer strictures and had their disease activity found earlier.

August 8th 2022

Better Knowledge of EoE Results in Reduced Diagnostic Delay for European Patients

Alisha Lekh

European patients with eosinophilic esophagitis (EoE) had an improved diagnosis process and a faster diagnosis as new clinical practice guidelines were published over time, according to the results of a recent study.

August 6th 2022

B7-H4 Identified as Potential Biomarker for CRSwNP in New Study